CN106177075A - The cold compress bag for the treatment of allergic skin and preparation method thereof - Google Patents
The cold compress bag for the treatment of allergic skin and preparation method thereof Download PDFInfo
- Publication number
- CN106177075A CN106177075A CN201610568004.9A CN201610568004A CN106177075A CN 106177075 A CN106177075 A CN 106177075A CN 201610568004 A CN201610568004 A CN 201610568004A CN 106177075 A CN106177075 A CN 106177075A
- Authority
- CN
- China
- Prior art keywords
- bag
- weight portion
- radix
- cold compress
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims description 48
- 208000010668 atopic eczema Diseases 0.000 title abstract description 18
- 230000000172 allergic effect Effects 0.000 title abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 104
- 239000007788 liquid Substances 0.000 claims abstract description 44
- 238000009833 condensation Methods 0.000 claims abstract description 35
- 230000005494 condensation Effects 0.000 claims abstract description 35
- 239000003822 epoxy resin Substances 0.000 claims abstract description 32
- 229920000647 polyepoxide Polymers 0.000 claims abstract description 32
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 18
- 239000004744 fabric Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 64
- 229940079593 drug Drugs 0.000 claims description 43
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 38
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 claims description 31
- -1 glycerol ester Chemical class 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 25
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 20
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 20
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 20
- 241000180649 Panax notoginseng Species 0.000 claims description 19
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 19
- 239000002023 wood Substances 0.000 claims description 19
- 241000628997 Flos Species 0.000 claims description 18
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 18
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 18
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims description 18
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 238000004821 distillation Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- 239000002671 adjuvant Substances 0.000 claims description 16
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 16
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 14
- 239000009636 Huang Qi Substances 0.000 claims description 14
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 14
- 229960000502 poloxamer Drugs 0.000 claims description 14
- 229920001983 poloxamer Polymers 0.000 claims description 14
- 239000000600 sorbitol Substances 0.000 claims description 14
- 238000009835 boiling Methods 0.000 claims description 13
- 208000017520 skin disease Diseases 0.000 claims description 13
- 206010048768 Dermatosis Diseases 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 206010002198 Anaphylactic reaction Diseases 0.000 claims description 11
- 230000036783 anaphylactic response Effects 0.000 claims description 11
- 208000003455 anaphylaxis Diseases 0.000 claims description 11
- 239000004288 Sodium dehydroacetate Substances 0.000 claims description 10
- 229940079839 sodium dehydroacetate Drugs 0.000 claims description 10
- 235000019259 sodium dehydroacetate Nutrition 0.000 claims description 10
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 claims description 10
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 claims description 9
- 229960004025 sodium salicylate Drugs 0.000 claims description 9
- 239000004698 Polyethylene Substances 0.000 claims description 8
- 239000000440 bentonite Substances 0.000 claims description 8
- 229910000278 bentonite Inorganic materials 0.000 claims description 8
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 8
- 229920000573 polyethylene Polymers 0.000 claims description 8
- 239000000377 silicon dioxide Substances 0.000 claims description 8
- 238000003860 storage Methods 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 230000033228 biological regulation Effects 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000011084 recovery Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 5
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 5
- 235000020778 linoleic acid Nutrition 0.000 claims description 5
- 235000012239 silicon dioxide Nutrition 0.000 claims description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 229960001866 silicon dioxide Drugs 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 238000009958 sewing Methods 0.000 claims 1
- 238000009987 spinning Methods 0.000 claims 1
- 238000010025 steaming Methods 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 18
- 208000024891 symptom Diseases 0.000 abstract description 4
- 206010047139 Vasoconstriction Diseases 0.000 abstract description 3
- 230000025033 vasoconstriction Effects 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 description 19
- 238000012360 testing method Methods 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 11
- 241000700199 Cavia porcellus Species 0.000 description 10
- 201000004624 Dermatitis Diseases 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 6
- 208000024780 Urticaria Diseases 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 210000000627 locus coeruleus Anatomy 0.000 description 6
- 244000025254 Cannabis sativa Species 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 235000014676 Phragmites communis Nutrition 0.000 description 5
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 5
- 235000021286 stilbenes Nutrition 0.000 description 5
- 229920002307 Dextran Polymers 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 238000002242 deionisation method Methods 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 206010012442 Dermatitis contact Diseases 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 241000721454 Pemphigus Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 208000010247 contact dermatitis Diseases 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 235000015858 Aloe ferox Nutrition 0.000 description 2
- 244000101643 Aloe ferox Species 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 238000011725 BALB/c mouse Methods 0.000 description 2
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 2
- 241001000583 Cryptotympana atrata Species 0.000 description 2
- 241000221079 Euphorbia <genus> Species 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001062009 Indigofera Species 0.000 description 2
- 241000581650 Ivesia Species 0.000 description 2
- 241001071917 Lithospermum Species 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000219050 Polygonaceae Species 0.000 description 2
- 244000292697 Polygonum aviculare Species 0.000 description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 description 2
- 241000243142 Porifera Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229960003699 evans blue Drugs 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000004744 fore-foot Anatomy 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 2
- 229960001660 histamine phosphate Drugs 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 244000001632 Acorus gramineus Species 0.000 description 1
- 241000544682 Acorus tatarinowii Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 241000130784 Arnebia euchroma Species 0.000 description 1
- 241001050829 Arnebia guttata Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 206010012468 Dermatitis herpetiformis Diseases 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 241000729170 Dipsacus asper Species 0.000 description 1
- 241001050741 Dipsacus asperoides Species 0.000 description 1
- 244000192024 Euphorbia helioscopia Species 0.000 description 1
- 235000012043 Euphorbia helioscopia Nutrition 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 241000292343 Hydnocarpus hainanensis Species 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 241000334154 Isatis tinctoria Species 0.000 description 1
- 241000731961 Juncaceae Species 0.000 description 1
- 244000003187 Juncus effusus Species 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- 241001170080 Lonicera hypoglauca Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 241000382362 Persicaria tinctoria Species 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 241001079007 Phellodendron chinense Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- 241001146210 Senecio scandens Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000488874 Sonchus Species 0.000 description 1
- 241000489357 Sonchus brachyotus Species 0.000 description 1
- 241000257673 Strobilanthes cusia Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 241001197778 Tripterygium hypoglaucum Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0052—Body part for treatment of skin or hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0098—Heating or cooling appliances for medical or therapeutic treatment of the human body ways of manufacturing heating or cooling devices for therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0203—Cataplasms, poultices or compresses, characterised by their contents; Bags therefor
- A61F2007/0215—Cataplasms, poultices or compresses, characterised by their contents; Bags therefor containing liquids other than water
- A61F2007/0219—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0203—Cataplasms, poultices or compresses, characterised by their contents; Bags therefor
- A61F2007/022—Bags therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0225—Compresses or poultices for effecting heating or cooling connected to the body or a part thereof
- A61F2007/0228—Compresses or poultices for effecting heating or cooling connected to the body or a part thereof with belt or strap, e.g. with buckle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0261—Compresses or poultices for effecting heating or cooling medicated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0261—Compresses or poultices for effecting heating or cooling medicated
- A61F2007/0265—Compresses or poultices for effecting heating or cooling medicated antiallergic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/3606—General characteristics of the apparatus related to heating or cooling cooled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/04—Skin
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Thermal Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to treat the cold compress bag of allergic skin, including bag, described bag includes medicated bag and the condensation bag being overlapped mutually setting, separated by the nonwoven layer that thickness is 1 5mm between described medicated bag and condensation bag, it is made up of waterproof fabrics outside described medicated bag, described condensation bag is made up of non-woven fabrics, and described medicated bag includes that the content in bag and liquid medicine, described condensation bag include the epoxy resin in bag;Medicated bag and condensation bag are respectively provided with active ingredient of Chinese herbs, make cold compress bag promote vasoconstriction, alleviate pruritus, relief of symptoms, have alleviation pruritus and the effect of detumescence, have the features such as treatment cycle is short, instant effect, expense are low.
Description
Technical field
The invention belongs to Traditional chinese medicine medicament field, particularly to a kind of cold compress bag treating allergic skin and preparation method thereof.
Background technology
In common allergy (allergy) dermatoses, major skin pruritus, urticaria, neurodermatitis, contact
Dermatitis and pemphigus etc..Skin pruritus, the traditional Chinese medical science is referred to as " pruritus ".Urticaria, the traditional Chinese medical science claims " urticaria ", is commonly called as " rubella wheal ".God
Through property dermatitis, in existing " stubborn dermatitis ", " chronic eczema ", " psoriasis " etc..Contact dermatitis, the traditional Chinese medical science referred to as " pollen skin ulcer ", " dermatitis rhus ",
" contact dermatitis from plaster " etc..Pemphigus, the traditional Chinese medical science is referred to as " pemphigus ", " red-fire ulcers, dermatitis herpetiformis ".These dermatosiss belong to skin allergic reaction (mistake
Quick) category, the most relatively common and be difficult to thoroughly cure, bring great misery to patient.
Effectively treat allergy (allergy) property disease at present, main employing antiallergic or anti-inflammatory drug treatment, but multiple
The rate of sending out is the highest.Key agents have cetirizine, imidazoles this sting, ranitidine, and methylprednisolone etc., Chinese medicine has Thunder God
Rattan, Tripterygium hypoglaucum, fangfeng tongsheng pill, YUPINGFENG SAN, WUSHE ZHIYANG WAN, pathogenic wind expelling electuary etc., but existing patient is difficult to accept
Hormone and the chemicals toxic and side effects to human body, be more willing to take TCM in Vitro to treat, and present stage be the absence of medicine for external use very much
The treatment of thing.And existing external medication method, mostly there is DeGrain, the technical problems such as curative effect of medication is short.
Summary of the invention
Present invention seek to address that technical problem present in prior art.To this end, it is an object of the present invention to propose
A kind of cold compress bag treating allergic skin, this cold compress bag is evident in efficacy, external use;This cold compress bag promotes vasoconstriction, subtracts
Light pruritus, relief of symptoms, there is alleviation pruritus and the effect of detumescence, there is the features such as treatment cycle is short, instant effect, expense are low,
And can the most thoroughly treat allergic skin.
Technical scheme is as follows:
A kind of cold compress bag treating allergic skin, including bag, described bag include being overlapped mutually setting medicated bag and
Condensation bag, is separated by the nonwoven layer that thickness is 1-5mm, by the anti-water surface outside described medicated bag between described medicated bag and condensation bag
Material is made, and described condensation bag is made up of non-woven fabrics;
Described medicated bag includes that the content in bag and liquid medicine, described content are mainly prepared from by following crude drug: horse
Tooth bamboo water pipe 3-12 weight portion, Radix Arnebiae (Radix Lithospermi) 2-6 weight portion, Herba Sonchi Oleracei 3-9 weight portion, Radix Notoginseng 1-5 weight portion, Herba Euphorbiae Helioscopiae 1-5 weight portion, strong wind
Sub-0.5-3 weight portion, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan 0.5-3 weight portion;
Described liquid medicine is mainly prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 10-20 weight portion, Radix Astragali 10-20 weight portion, and one
Branch Artemisia 10-20 weight portion, Cortex Phellodendri 5-18 weight portion, Herba Senecionis Scandentis 5-15 weight portion, Indigo Naturalis 5-15 weight portion, Spica Prunellae 3-11 weight
Part, Cortex Mori 5-15 weight portion;
Described condensation bag includes the epoxy resin in bag, and described epoxy resin is mainly prepared from by following raw material: methylol is fine
Dimension element sodium 50-80 weight portion, hydrogenated wood rosin glycerol ester 10-30 weight portion, menthyl lactate 5-20 weight portion, Oleum menthae 0.5-3 weight
Part.
Chinese medicine extract of the present invention passes through kinds of traditional Chinese medicines compatibility, has the effect alleviating pruritus and detumescence, to anaphylaxis skin
The treatment of skin has significant curative effect.Wherein epoxy resin is using Carboxymethyl cellulose sodium and hydrogenated wood rosin glycerol ester as gel-type vehicle, has
Stronger swelling function, forms space net structure after water suction, can absorb the medicinal liquid of medicated bag well through nonwoven layer, effectively
Act on target site;Menthyl lactate and Oleum menthae are collaborative to be used, and improves the cooling blood and removing stasis of medicine, lenitive further
Effect, and effect is lasting.
Further improve the curative effect of cold compress bag treatment allergic skin, prepare described content and also include following raw material
Medicine: Flos Lonicerae 3-9 weight portion, Radix Glycyrrhizae Preparata 1-5 weight portion, Radix Paeoniae Alba 1-5 weight portion, store 0.5-3 weight portion, Periostracum Cicadae 0.5-3 weight
Amount part.
Further, prepare described liquid medicine and also include following crude drug: Medulla Junci 5-20 weight portion, Radix Dipsaci 5-15 weight
Part, Rhizoma Acori Graminei 5-15 weight portion, Radix Platycodonis 1-5 weight portion, fresh Rhizoma Phragmitis 1-5 weight portion, Fructus Gardeniae 3-9 weight portion.
In further preferred version, prepare described epoxy resin and also include following raw material: sorbitol 2-8 weight portion, pool
Luo Shamu 10-20 weight portion.Poloxamer has stronger surface-active action, and in the present invention, it is as surfactant
Not only can increase the contact area of penetrating fluid and skin, and be used in conjunction with sorbitol, improve antibacterial ability, extend medicine and protect
Deposit the phase;Meanwhile, poloxamer has certain gelatification, improves the molding of epoxy resin further;Additionally, poloxamer and hydrogenation
Rosin ester synergism, extends the action time of pharmaceutical through skin, extends curative effect, improves patient compliance.
The present invention is in an improvement project, and described content also includes adjuvant, crude drug and adjuvant in described content
Ratio of weight and number be 1:0.1-0.6;Described adjuvant includes linoleic acid 10-30 weight portion, sodium dehydroacetate 8-20 weight portion, water
Poplar acid sodium 3-12 weight portion.Linoleic interpolation, is beneficial to improve the osmosis of gel-type vehicle, sodium dehydroacetate and sodium salicylate
Adjuvant is used in conjunction with having good Antimicrobial preservative ability, extends the storage life of medicine.
Described adjuvant also includes Bentonite 15-35 weight portion and colloidality silica 1 0-25 weight portion.Both adjuvant is common
Using, beneficially content dispersion in liquid medicine suspends, it is to avoid because microgranule is saved bit by bit on nonwoven layer wall, cause obstruction.
Further in scheme, the nonwoven layer thickness between described medicated bag and condensation bag is 2.2mm;This thickness makes liquid medicine
Can permeate well and pass through, and can preferable coutroi velocity.
Nonwoven layer surface outside described condensation bag is provided with tearable cover layer, and described cover layer is that polyethylene film covers
Cap rock.
It is a further object to provide the preparation method of a kind of above-mentioned cold compress bag, described method includes following step
Rapid:
The preparation of (a) content: weigh the Herba portulacae of formula ratio, Radix Arnebiae (Radix Lithospermi), Herba Sonchi Oleracei, Radix Notoginseng, Herba Euphorbiae Helioscopiae, Semen Hydnocarpi, Caulis et Folium Hyptidis suaveolentis
Grass, Flos Lonicerae, Radix Glycyrrhizae Preparata, the Radix Paeoniae Alba, storage and Periostracum Cicadae, pulverize, and crosses 60 mesh sieves, obtains content;
The preparation of (b) liquid medicine:
(b-1) take the Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) of described weight portion, Radix Platycodonis, Spica Prunellae, fresh Rhizoma Phragmitis distillation extraction, obtain volatile oil, and receive
Aqueous solution after collection distillation;
(b-2) Herba Achilleae of formula ratio, Cortex Phellodendri, Herba Senecionis Scandentis, Indigo Naturalis, Cortex Mori, Medulla Junci, Radix Dipsaci, Rhizoma Acori Graminei, Huang are weighed
After stilbene, Fructus Gardeniae boiling 3 hours, add the medicinal residues after distillation in step (b-1), boiling twice, each 1 hour,
Merging decoction liquor, filter, after filtration, the aqueous solution with step (b-1) merges, and is concentrated into magma shape, is cooled to room temperature, adds ethanol
Making alcohol content is 65%, stirring, stands 24 hours, after taking supernatant recovery ethanol, obtains liquid medicine;
C (), by the content of step (a) of preparation and the liquid medicine mixing and stirring of step (b), adds the Asia of formula ratio
Oleic acid, Bentonite, colloidality silicon dioxide, sodium dehydroacetate and sodium salicylate, after mix homogeneously, obtain medicated bag mixture, standby;
The preparation of (d) epoxy resin
(d-1) weigh the Carboxymethyl cellulose sodium of formula ratio, hydrogenated wood rosin glycerol ester and poloxamer, add appropriate deionization
Water mix homogeneously, obtains mixed liquor, standby;
(d-2) menthyl lactate weighing formula ratio is dissolved in ethanol, obtains menthyl lactate ethanol solution, standby;
(d-3) weigh Oleum menthae and the sorbitol of formula ratio, and add the mixed liquor of step (d-1) and step (d-2)
Menthyl lactate ethanol solution, adds suitable quantity of water regulation viscosity, stirs, obtain epoxy resin;
The preparation of (e) condensation bag: epoxy resin prepared for step (d-3) is spread evenly across non-woven fabrics inner face, then by nothing
Spin together with cloth side and medicated bag inside edge sew, outside non-woven fabrics, press polyethylene film cover, non-fill medicine
The cold compress bag of bag;
F medicated bag mixture prepared for step (c) is poured in step (e) in the medicated bag of cold compress bag by (), sealing, packaging, i.e.
The cold compress bag of allergic skin must be treated.
The present invention treats the cold compress bag of allergic skin, can be by connecting adhesive tape in the outside of medicated bag, by cold compress bag
Paste and be fixed on target site.Cold compress bag can promote vasoconstriction, alleviates contrafluxion, eases the pain, and relief of symptoms has very
Good alleviation pruritus and detumescence effect, the good effect for the treatment of allergic skin.Additionally, this cold compress bag changes tradition directly by medicine
It is blended in the preparation method of gel layer, is spaced apart by medicated bag and gel pockets, improves medicine stability, it is to avoid in some medicines easily
The inefficacy of oxidizing component, it is ensured that drug effect, and extend storage life;In use, medicinal liquid slowly oozes out, and further increases cold compress bag
The drug effect phase.The processing preparation process of cold compress bag of the present invention is simple, easy to use, has good market prospect.
The source of the raw material of Chinese medicine composition of the present invention:
Herba Portulacae: this product is portulacaceous plant Herba Portulacae Portulaca oleracea L..
Radix Arnebiae (Radix Lithospermi): this product is comfrey lithospermum euchromum Royle Arnebia euchroma (Royle) Johnst., Radix Arnebiae (Radix Lithospermi)
Lithospermum erythrorhizon Sieb.et Zucc. or arnebia guttata Bunge Arnebia guttata Bunge is dried
Root.
Herba Sonchi Oleracei: the herb of Compositae sonchus plant Herba Sonchi Arvensis Sonchus Brachyotus DC..
Radix Notoginseng: this product is the dry root of panax araliaceae plant Panax notoginseng (Burk.) F.H.Chen.
Herba Euphorbiae Helioscopiae: Euphorbiaceae euphorbia Herba Euphorbiae Helioscopiae Euphorbia helioscopia L., with all herbal medicine.
Semen Hydnocarpi: for Flacourtiaceae plant Semen Hydnocarpi, the mature seed of Hydnocarpus hainanensis (Merr.) Sleum..
Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan: for the herb of labiate Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan.
Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi): for root and the leaf of euphorbia plant comospore Fructus glochidionis puberi(Herba Glochidii Puberi).
The Radix Astragali: this product is leguminous plant Radix Astagali Astragalus membranaceus (Fisch.)
Bge.var.mongholicus (Bge.) Hsiao's or Radix Astragali Astragalus membranaceus (Fisch.) Bge.
Dry root.
Herba Achilleae: for feverfew Millefolium or the herb of southwest achillea millefolium.
Cortex Phellodendri: this product is rutaceae wampee Phellodendron chinense Schneid. or Cortex Phellodendri
The dry bark of Phellodendron amurense Rupr..
Herba Senecionis Scandentis: this product is Compositae Senecio plant Herba Senecionis Scandentis Senecio scandens Buch.-Ham., with herb
It is used as medicine.
Indigo Naturalis: this product is acanthaceous vegetable acanthaceous indigo Baphicacanthus cusia (Nees) Bremek., polygonaceae plant knotweed
Blue Polygonum tinctorium Ait. or the leaf of cruciferae isatis Isatis indigotica Fort. or stem
The processed prepared dried powder of leaf or agglomerate.
Spica Prunellae: this product is the dry fruit ear of labiate Spica Prunellae Prunella vulgaris L..
Cortex Mori: this product is the dry root bark of moraceae plants Mulberry Morus alba L..
Flos Lonicerae: this product is caprifoliaceae plant Radix Ophiopogonis Lonicera japonica Thunb., Flos Lonicerae Lonicera
Hypoglauca Miq., Flos Lonicerae (hair calyx Radix Ophiopogonis) Lonicera confusa DC. or hair style Radix Ophiopogonis Lonicera
The flower that the dry flower of dasystyla Rehd. or band are just opened.
Radix Glycyrrhizae Preparata: this product is the Preparation process product of Radix Glycyrrhizae.
The Radix Paeoniae Alba: this product is the dry root of ranunculaceae plant Radix Paeoniae Paeonia lactiflora Pall..
Store: for the Herb of polygonaceae plant axillary flower knotweed.
Periostracum Cicadae: when this product is the larva emergence of cicada Cryptotympana atrata Fabr. Cryptotympana pustulata Fabricius
Exuviae shell.
Medulla Junci: the dry stem pith of rush family plant Medulla Junci Juncus effusus L..
Radix Dipsaci: this product is Dipsacaceae plant Radix Dipsaci Dipsacus asperoides C.Y.Cheng et T.M.Ai
The dry root of (or Dipsacus asper Wall).
Rhizoma Acori Graminei: this product is the dry rhizome of acorus gramineus araceae plant Acorus tatarinowii Schott.
Radix Platycodonis: this product is the dry root of Campanulaceae Radix Platycodonis Platycodon grandiflorum (Jacq.) A.DC..
Fresh Rhizoma Phragmitis: this product is liliaceous plant Aloe vulgaris Aloe barbadensis Miller, Aloe ferox Miller
Aloe ferox Miller or other belong to the fresh root of kindred plant leaf together.
Fructus Gardeniae: this product is the dry mature fruit of Maguireothamnus speciosus Fructus Gardeniae Gardenia jasminoides Ellis.
Accompanying drawing explanation
Fig. 1 is the overall structure schematic diagram of cold compress bag of the present invention;
Fig. 2 is the cross sectional representation of cold compress bag of the present invention.
Detailed description of the invention
A kind of cold compress bag treating allergic skin of the present invention, as shown in Figure 1-2, including bag 1, described bag 1 includes
It is overlapped mutually medicated bag 2 and the condensation bag 3 of setting, by nonwoven layer 4 that thickness is 1-5mm between described medicated bag 2 and condensation bag 3
Separating, preferred thickness is 2.2mm;Being made up of waterproof fabrics outside described medicated bag 2, described condensation bag 3 is made up of non-woven fabrics.Described
Medicated bag 2 includes that the content in bag and liquid medicine, described condensation bag 3 include the epoxy resin in bag;Activity one-tenth in medicated bag 2 of the present invention
The detailed description of the invention of the epoxy resin composition dividing and condensing bag 3 is as follows.
Embodiment 1
The prescription of the present embodiment bag is:
Medicated bag:
Content is mainly prepared from by following crude drug: Herba Portulacae 30g, Radix Arnebiae (Radix Lithospermi) 20g, Herba Sonchi Oleracei 30g, Radix Notoginseng 10g, pool
Paint 10g, Semen Hydnocarpi 5g, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan 5g.
Liquid medicine is mainly prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 100g, Radix Astragali 100g, Herba Achilleae 100g, Cortex Phellodendri 50g,
Herba Senecionis Scandentis 50g, Indigo Naturalis 50g, Spica Prunellae 30g, Cortex Mori 50g.
Condensation bag:
Carboxymethyl cellulose sodium 500g, hydrogenated wood rosin glycerol ester 100g, menthyl lactate 50g, Oleum menthae 5g.
Embodiment 2
The prescription of the present embodiment bag is:
Medicated bag:
Content is mainly prepared from by following crude drug: Herba Portulacae 120g, Radix Arnebiae (Radix Lithospermi) 60g, Herba Sonchi Oleracei 90g, Radix Notoginseng 50g,
Herba Euphorbiae Helioscopiae 50g, Semen Hydnocarpi 30g, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan 30g.
Liquid medicine is mainly prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 200g, Radix Astragali 200g, Herba Achilleae 200g, Cortex Phellodendri 180g,
Herba Senecionis Scandentis 150g, Indigo Naturalis 150g, Spica Prunellae 110g, Cortex Mori 150g.
Condensation bag:
Carboxymethyl cellulose sodium 800g, hydrogenated wood rosin glycerol ester 300g, menthyl lactate 200g, Oleum menthae 30g.
Embodiment 3
The prescription of the present embodiment bag is:
Medicated bag:
Content is prepared from by following crude drug: Herba Portulacae 45g, Radix Arnebiae (Radix Lithospermi) 30g, Herba Sonchi Oleracei 60g, Radix Notoginseng 30g, Herba Euphorbiae Helioscopiae
30g, Semen Hydnocarpi 20g, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan 20g, Flos Lonicerae 30g, Radix Glycyrrhizae Preparata 10g, Radix Paeoniae Alba 10g, store 5g, Periostracum Cicadae 5g.
Liquid medicine is prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 150g, Radix Astragali 150g, Herba Achilleae 150g, Cortex Phellodendri 100g, a thousand li
Light 100g, Indigo Naturalis 100g, Spica Prunellae 60g, Cortex Mori 100g, Medulla Junci 50g, Radix Dipsaci 50g, Rhizoma Acori Graminei 50g, Radix Platycodonis 10g, fresh reed
Root 10g, Fructus Gardeniae 30g.Condensation bag:
Carboxymethyl cellulose sodium 600g, hydrogenated wood rosin glycerol ester 200g, menthyl lactate 100g, Oleum menthae 20g.
Preparation method:
The preparation of (a) content: weigh the Herba Portulacae of formula ratio, Radix Arnebiae (Radix Lithospermi), Herba Sonchi Oleracei, Radix Notoginseng, Herba Euphorbiae Helioscopiae, Semen Hydnocarpi, Caulis et Folium Hyptidis suaveolentis
Grass, Flos Lonicerae, Radix Glycyrrhizae Preparata, the Radix Paeoniae Alba, storage and Periostracum Cicadae, pulverize, and crosses 60 mesh sieves, obtains content, take 100g standby;
The preparation of (b) liquid medicine:
(b-1) take the Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) of described weight portion, Radix Platycodonis, Spica Prunellae, fresh Rhizoma Phragmitis distillation extraction, obtain volatile oil, and receive
Aqueous solution after collection distillation;
(b-2) Herba Achilleae of formula ratio, Cortex Phellodendri, Herba Senecionis Scandentis, Indigo Naturalis, Cortex Mori, Medulla Junci, Radix Dipsaci, Rhizoma Acori Graminei, Huang are weighed
After stilbene, Fructus Gardeniae boiling 3 hours, add the medicinal residues after distillation in step (b-1), boiling twice, each 1 hour,
Merging decoction liquor, filter, after filtration, the aqueous solution with step (b-1) merges, and is concentrated into magma shape, is cooled to room temperature, adds ethanol
Making alcohol content is 65%, stirring, stands 24 hours, after taking supernatant recovery ethanol, and cold cut, obtain liquid medicine, take 250g standby;
C (), by the content of step (a) of preparation and the liquid medicine mixing and stirring of step (b), obtains medicated bag mixture, standby
With;
The preparation of (d) epoxy resin
(d-1) weigh the Carboxymethyl cellulose sodium of formula ratio, hydrogenated wood rosin glycerol ester, add appropriate deionized water mixing all
Even, obtain mixed liquor, standby;
(d-2) menthyl lactate weighing formula ratio is dissolved in ethanol, obtains menthyl lactate ethanol solution, standby;
(d-3) weigh the Oleum menthae of formula ratio, and add mixed liquor and the lactic acid Herba Menthae of step (d-2) of step (d-1)
Ester ethanol solution, adds suitable quantity of water regulation viscosity, stirs, obtain epoxy resin, take 120g standby;
The preparation of (e) condensation bag: epoxy resin prepared for step (d-3) is spread evenly across non-woven fabrics inner face, then by nothing
Spin together with cloth side and medicated bag inside edge sew, outside non-woven fabrics, press polyethylene film cover, non-fill medicine
The cold compress bag of bag;
F medicated bag mixture prepared for step (c) is poured in step (e) in the medicated bag of cold compress bag by (), sealing, packaging, i.e.
The cold compress bag of allergic skin must be treated.
Embodiment 4
The prescription of the present embodiment bag is:
Medicated bag:
Content is prepared from by following crude drug: Herba Portulacae 45g, Radix Arnebiae (Radix Lithospermi) 30g, Herba Sonchi Oleracei 60g, Radix Notoginseng 30g, Herba Euphorbiae Helioscopiae
30g, Semen Hydnocarpi 20g, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan 20g, Flos Lonicerae 30g, Radix Glycyrrhizae Preparata 10g, Radix Paeoniae Alba 10g, store 5g, Periostracum Cicadae 5g.
Liquid medicine is prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 150g, Radix Astragali 150g, Herba Achilleae 150g, Cortex Phellodendri 100g, a thousand li
Light 100g, Indigo Naturalis 100g, Spica Prunellae 60g, Cortex Mori 100g, Medulla Junci 50g, Radix Dipsaci 50g, Rhizoma Acori Graminei 50g, Radix Platycodonis 10g, fresh reed
Root 10g, Fructus Gardeniae 30g.Condensation bag:
Carboxymethyl cellulose sodium 600g, hydrogenated wood rosin glycerol ester 200g, menthyl lactate 100g, Oleum menthae 20g, sorbitol 20g,
Poloxamer 100g.
Preparation method:
The preparation of (a) content: weigh the Herba Portulacae of formula ratio, Radix Arnebiae (Radix Lithospermi), Herba Sonchi Oleracei, Radix Notoginseng, Herba Euphorbiae Helioscopiae, Semen Hydnocarpi, Caulis et Folium Hyptidis suaveolentis
Grass, Flos Lonicerae, Radix Glycyrrhizae Preparata, the Radix Paeoniae Alba, storage and Periostracum Cicadae, pulverize, and crosses 60 mesh sieves, obtains content, take 100g standby;
The preparation of (b) liquid medicine:
(b-1) take the Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) of described weight portion, Radix Platycodonis, Spica Prunellae, fresh Rhizoma Phragmitis distillation extraction, obtain volatile oil, and receive
Aqueous solution after collection distillation;
(b-2) Herba Achilleae of formula ratio, Cortex Phellodendri, Herba Senecionis Scandentis, Indigo Naturalis, Cortex Mori, Medulla Junci, Radix Dipsaci, Rhizoma Acori Graminei, Huang are weighed
After stilbene, Fructus Gardeniae boiling 3 hours, add the medicinal residues after distillation in step (b-1), boiling twice, each 1 hour,
Merging decoction liquor, filter, after filtration, the aqueous solution with step (b-1) merges, and is concentrated into magma shape, is cooled to room temperature, adds ethanol
Making alcohol content is 65%, stirring, stands 24 hours, after taking supernatant recovery ethanol, obtains liquid medicine, takes 250g standby;
C (), by the content of step (a) of preparation and the liquid medicine mixing and stirring of step (b), obtains medicated bag mixture, standby
With;
The preparation of (d) epoxy resin
(d-1) weigh the Carboxymethyl cellulose sodium of formula ratio, hydrogenated wood rosin glycerol ester and poloxamer, add appropriate deionization
Water mix homogeneously, obtains mixed liquor, standby;
(d-2) menthyl lactate weighing formula ratio is dissolved in ethanol, obtains menthyl lactate ethanol solution, standby;
(d-3) weigh Oleum menthae and the sorbitol of formula ratio, and add the mixed liquor of step (d-1) and step (d-2)
Menthyl lactate ethanol solution, adds suitable quantity of water regulation viscosity, stirs, obtain epoxy resin, take 120g standby;
The preparation of (e) condensation bag: epoxy resin prepared for step (d-3) is spread evenly across non-woven fabrics inner face, then by nothing
Spin together with cloth side and medicated bag inside edge sew, outside non-woven fabrics, press polyethylene film cover, non-fill medicine
The cold compress bag of bag;
F medicated bag mixture prepared for step (c) is poured in step (e) in the medicated bag of cold compress bag by (), sealing, packaging, i.e.
The cold compress bag of allergic skin must be treated.
Embodiment 5
The prescription of the present embodiment bag is:
Medicated bag:
Content is prepared from by following crude drug: Herba Portulacae 80g, Radix Arnebiae (Radix Lithospermi) 40g, Herba Sonchi Oleracei 70g, Radix Notoginseng 35g, Herba Euphorbiae Helioscopiae
25g, Semen Hydnocarpi 25g, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan 25g, Flos Lonicerae 90g, Radix Glycyrrhizae Preparata 50g, Radix Paeoniae Alba 50g, store 30g, Periostracum Cicadae 30g.
Liquid medicine is prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 180g, Radix Astragali 180g, Herba Achilleae 180g, Cortex Phellodendri 120g, a thousand li
Light 120g, Indigo Naturalis 120g, Spica Prunellae 80g, Cortex Mori 120g, Medulla Junci 200g, Radix Dipsaci 150g, Rhizoma Acori Graminei 150g, Radix Platycodonis 50g,
Fresh Rhizoma Phragmitis 50g, Fructus Gardeniae 90g.
Condensation bag:
Carboxymethyl cellulose sodium 650g, hydrogenated wood rosin glycerol ester 150g, menthyl lactate 100g, Oleum menthae 15g, sorbitol 60g,
Poloxamer 150g.
Preparation method: preparation method as described in Example 4.
Embodiment 6
The prescription of the present embodiment bag is:
Medicated bag:
Content is prepared from by following crude drug and adjuvant:
Crude drug: Herba Portulacae 60g, Radix Arnebiae (Radix Lithospermi) 35g, Herba Sonchi Oleracei 50g, Radix Notoginseng 25g, Herba Euphorbiae Helioscopiae 25g, Semen Hydnocarpi 15g, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan
25g, Flos Lonicerae 55g, Radix Glycyrrhizae Preparata 25g, Radix Paeoniae Alba 25g, store 15g, Periostracum Cicadae 15g;
Adjuvant: linoleic acid 100g, sodium dehydroacetate 80g, sodium salicylate 30g.
Liquid medicine is prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 120g, Radix Astragali 120g, Herba Achilleae 120g, Cortex Phellodendri 80g, a thousand li
Light 80g, Indigo Naturalis 70g, Spica Prunellae 70g, Cortex Mori 70g, Medulla Junci 120g, Radix Dipsaci 100g, Rhizoma Acori Graminei 100g, Radix Platycodonis 30g, fresh reed
Root 30g, Fructus Gardeniae 50g.
Condensation bag:
Carboxymethyl cellulose sodium 750g, hydrogenated wood rosin glycerol ester 250g, menthyl lactate 150g, Oleum menthae 25g, sorbitol 80g,
Poloxamer 200g.
Preparation method:
The preparation of (a) content: weigh the Herba Portulacae of formula ratio, Radix Arnebiae (Radix Lithospermi), Herba Sonchi Oleracei, Radix Notoginseng, Herba Euphorbiae Helioscopiae, Semen Hydnocarpi, Caulis et Folium Hyptidis suaveolentis
Grass, Flos Lonicerae, Radix Glycyrrhizae Preparata, the Radix Paeoniae Alba, storage and Periostracum Cicadae, pulverize, and crosses 60 mesh sieves, obtains content, take 150g standby;
The preparation of (b) liquid medicine:
(b-1) take the Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) of described weight portion, Radix Platycodonis, Spica Prunellae, fresh Rhizoma Phragmitis distillation extraction, obtain volatile oil, and receive
Aqueous solution after collection distillation;
(b-2) Herba Achilleae of formula ratio, Cortex Phellodendri, Herba Senecionis Scandentis, Indigo Naturalis, Cortex Mori, Medulla Junci, Radix Dipsaci, Rhizoma Acori Graminei, Huang are weighed
After stilbene, Fructus Gardeniae boiling 3 hours, add the medicinal residues after distillation in step (b-1), boiling twice, each 1 hour,
Merging decoction liquor, filter, after filtration, the aqueous solution with step (b-1) merges, and is concentrated into magma shape, is cooled to room temperature, adds ethanol
Making alcohol content is 65%, stirring, stands 24 hours, after taking supernatant recovery ethanol, obtains liquid medicine, takes 200g standby;
C (), by the content of step (a) of preparation and the liquid medicine mixing and stirring of step (b), adds the Asia of formula ratio
Oleic acid, sodium dehydroacetate and sodium salicylate, after mix homogeneously, obtain medicated bag mixture, standby;
The preparation of (d) epoxy resin
(d-1) weigh the Carboxymethyl cellulose sodium of formula ratio, hydrogenated wood rosin glycerol ester and poloxamer, add appropriate deionization
Water mix homogeneously, obtains mixed liquor, standby;
(d-2) menthyl lactate weighing formula ratio is dissolved in ethanol, obtains menthyl lactate ethanol solution, standby;
(d-3) weigh Oleum menthae and the sorbitol of formula ratio, and add the mixed liquor of step (d-1) and step (d-2)
Menthyl lactate ethanol solution, adds suitable quantity of water regulation viscosity, stirs, obtain epoxy resin, take 200g standby;
The preparation of (e) condensation bag: epoxy resin prepared for step (d-3) is spread evenly across non-woven fabrics inner face, then by nothing
Spin together with cloth side and medicated bag inside edge sew, outside non-woven fabrics, press polyethylene film cover, non-fill medicine
The cold compress bag of bag;
F medicated bag mixture prepared for step (c) is poured in step (e) in the medicated bag of cold compress bag by (), sealing, packaging, i.e.
The cold compress bag of allergic skin must be treated.
Embodiment 7
The prescription of the present embodiment bag is:
Medicated bag:
Content is prepared from by following crude drug and adjuvant:
Crude drug: Herba Portulacae 60g, Radix Arnebiae (Radix Lithospermi) 35g, Herba Sonchi Oleracei 50g, Radix Notoginseng 25g, Herba Euphorbiae Helioscopiae 25g, Semen Hydnocarpi 15g, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan
25g, Flos Lonicerae 55g, Radix Glycyrrhizae Preparata 25g, Radix Paeoniae Alba 25g, store 15g, Periostracum Cicadae 15g;
Adjuvant: linoleic acid 100g, sodium dehydroacetate 80g, sodium salicylate 30g, Bentonite 150g, colloidality silica 1 00g.
Liquid medicine is prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 120g, Radix Astragali 120g, Herba Achilleae 120g, Cortex Phellodendri 80g, a thousand li
Light 80g, Indigo Naturalis 70g, Spica Prunellae 70g, Cortex Mori 70g, Medulla Junci 120g, Radix Dipsaci 100g, Rhizoma Acori Graminei 100g, Radix Platycodonis 30g, fresh reed
Root 30g, Fructus Gardeniae 50g.
Condensation bag:
Carboxymethyl cellulose sodium 750g, hydrogenated wood rosin glycerol ester 250g, menthyl lactate 150g, Oleum menthae 25g, sorbitol 80g,
Poloxamer 200g.
Preparation method:
The preparation of (a) content: weigh the Herba Portulacae of formula ratio, Radix Arnebiae (Radix Lithospermi), Herba Sonchi Oleracei, Radix Notoginseng, Herba Euphorbiae Helioscopiae, Semen Hydnocarpi, Caulis et Folium Hyptidis suaveolentis
Grass, Flos Lonicerae, Radix Glycyrrhizae Preparata, the Radix Paeoniae Alba, storage and Periostracum Cicadae, pulverize, and crosses 60 mesh sieves, obtains content, take 150g standby;
The preparation of (b) liquid medicine:
(b-1) take the Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) of described weight portion, Radix Platycodonis, Spica Prunellae, fresh Rhizoma Phragmitis distillation extraction, obtain volatile oil, and receive
Aqueous solution after collection distillation;
(b-2) Herba Achilleae of formula ratio, Cortex Phellodendri, Herba Senecionis Scandentis, Indigo Naturalis, Cortex Mori, Medulla Junci, Radix Dipsaci, Rhizoma Acori Graminei, Huang are weighed
After stilbene, Fructus Gardeniae boiling 3 hours, add the medicinal residues after distillation in step (b-1), boiling twice, each 1 hour,
Merging decoction liquor, filter, after filtration, the aqueous solution with step (b-1) merges, and is concentrated into magma shape, is cooled to room temperature, adds ethanol
Making alcohol content is 65%, stirring, stands 24 hours, after taking supernatant recovery ethanol, obtains liquid medicine, takes 200g standby;
C (), by the content of step (a) of preparation and the liquid medicine mixing and stirring of step (b), adds the Asia of formula ratio
Oleic acid, Bentonite, colloidality silicon dioxide, sodium dehydroacetate and sodium salicylate, after mix homogeneously, obtain medicated bag mixture, standby;
The preparation of (d) epoxy resin
(d-1) weigh the Carboxymethyl cellulose sodium of formula ratio, hydrogenated wood rosin glycerol ester and poloxamer, add appropriate deionization
Water mix homogeneously, obtains mixed liquor, standby;
(d-2) menthyl lactate weighing formula ratio is dissolved in ethanol, obtains menthyl lactate ethanol solution, standby;
(d-3) weigh Oleum menthae and the sorbitol of formula ratio, and add the mixed liquor of step (d-1) and step (d-2)
Menthyl lactate ethanol solution, adds suitable quantity of water regulation viscosity, stirs, obtain epoxy resin, take 200g standby;
The preparation of (e) condensation bag: epoxy resin prepared for step (d-3) is spread evenly across non-woven fabrics inner face, then by nothing
Spin together with cloth side and medicated bag inside edge sew, outside non-woven fabrics, press polyethylene film cover, non-fill medicine
The cold compress bag of bag;
F medicated bag mixture prepared for step (c) is poured in step (e) in the medicated bag of cold compress bag by (), sealing, packaging, i.e.
The cold compress bag of allergic skin must be treated.
Embodiment 8
The prescription of the present embodiment bag is:
Medicated bag:
Content is prepared from by following crude drug and adjuvant:
Crude drug: Herba Portulacae 70g, Radix Arnebiae (Radix Lithospermi) 38g, Herba Sonchi Oleracei 55g, Radix Notoginseng 20g, Herba Euphorbiae Helioscopiae 20g, Semen Hydnocarpi 16g, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan
26g, Flos Lonicerae 50g, Radix Glycyrrhizae Preparata 26g, Radix Paeoniae Alba 26g, store 16g, Periostracum Cicadae 16g;
Adjuvant: linoleic acid 150g, sodium dehydroacetate 120g, sodium salicylate 50g, Bentonite 350g, colloidality silicon dioxide 250g.
Liquid medicine is prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 140g, Radix Astragali 140g, Herba Achilleae 140g, Cortex Phellodendri 80g, a thousand li
Light 80g, Indigo Naturalis 80g, Spica Prunellae 80g, Cortex Mori 80g, Medulla Junci 100g, Radix Dipsaci 120g, Rhizoma Acori Graminei 120g, Radix Platycodonis 15g, fresh reed
Root 30g, Fructus Gardeniae 60g.
Condensation bag:
Carboxymethyl cellulose sodium 650g, hydrogenated wood rosin glycerol ester 220g, menthyl lactate 180g, Oleum menthae 14g, sorbitol 40g,
Poloxamer 150g.
Preparation method: preparation method as described in Example 7.
Comparative examples
The prescription of the present embodiment bag is:
Active component is prepared from by following crude drug: Herba Portulacae 60g, Radix Arnebiae (Radix Lithospermi) 35g, Herba Sonchi Oleracei 50g, Radix Notoginseng 25g, Herba Euphorbiae Helioscopiae
25g, Semen Hydnocarpi 15g, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan 25g, Flos Lonicerae 55g, Radix Glycyrrhizae Preparata 25g, Radix Paeoniae Alba 25g, store 15g, Periostracum Cicadae 15g, and liquid medicine is by such as
Lower crude drug is prepared from: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 120g, Radix Astragali 120g, Herba Achilleae 120g, Cortex Phellodendri 80g, Herba Senecionis Scandentis 80g, Indigo Naturalis 70g, the summer
Hay 70g, Cortex Mori 70g, Medulla Junci 120g, Radix Dipsaci 100g, Rhizoma Acori Graminei 100g, Radix Platycodonis 30g, fresh Rhizoma Phragmitis 30g, Fructus Gardeniae 50g.
Epoxy resin: Carboxymethyl cellulose sodium 500g, hydrogenated wood rosin glycerol ester 100g, menthyl lactate 50g, Oleum menthae 5g.
Preparation method:
(1) weigh each crude drug in active component, boiling three times, each 1 hour, merge decoction liquor, filter, filter
After be concentrated into magma shape, be cooled to room temperature, add ethanol and make alcohol content be 65%, stirring, stands 24 hours, takes supernatant recovery second
After alcohol, obtain liquid medicine;
(2) weigh the Carboxymethyl cellulose sodium of formula ratio, hydrogenated wood rosin glycerol ester, add appropriate deionized water mix homogeneously,
Obtain mixed liquor, standby;The menthyl lactate weighing formula ratio is dissolved in ethanol, obtains menthyl lactate ethanol solution, standby;Weigh
The Oleum menthae of formula ratio, and add mixed liquor and menthyl lactate ethanol solution, add liquid medicine regulation viscosity, stir, i.e.
Obtain the epoxy resin of band liquid medicine.
Test example 1 stability test
The sample of above-described embodiment 1, embodiment 3-4, embodiment 6-7 and comparative examples 1 is carried out temperature, humidity and
Infiltrative influence factor tests, with the outward appearance of epoxy resin for reference index 1;Medicated bag is taken apart, with the dose of medicated bag as reference
Index 2;Cold compress bag is placed on sponge, with the medicated bag dose after 1h and outward appearance for reference index 3;The results are shown in Table 1.
Table 1 is the Acceleration study result of the test of test specimen
Condition: temperature40℃±2DEG C, under the conditions of humidity 75 ± 5%
Table 2 absorbs the result of the test of dose for sponge
Condition: under room temperature, humidity 60% ± 10%
The above results shows, embodiment 1,3-4,6-7 stability under the conditions of temperature 40 DEG C ± 2 DEG C, humidity 75 ± 5% is equal
Good than comparative examples 1, the wherein optimal stability of embodiment 7.The result of comparing embodiment 3 and embodiment 4 understands, and moors Lip river
The interpolation of husky nurse and sorbitol has moisturizing, promotees gelatification;The result of comparing embodiment 6 and embodiment 7 understands, Bentonite and glue
Property silicon dioxide add be beneficial to content dispersion, have suspending effect.
Test example 2 pharmacological toxicity is tested
Acute toxicity testing data
1, experimental technique
Depilatory is uniformly coated with by guinea pig back spinal column both sides, makes unhairing scope about 40 square centimeters.Clean depilatory
Returning cage to observe 24 hours, often group Cavia porcellus loses money in a business the cold compress bag of inventive embodiments 1, embodiment 3 and embodiment 7 respectively (by cold compress bag
Make 20 square centimeters of sizes), another group is coated with the every twice-daily of solvent 0.8ml, continuous one week, after experiment terminates, is put to death by Cavia porcellus,
The heart, liver, kidney and depilation skin do pathological examination.
2, result
Above-mentioned three groups of medication Cavia porcellus trunks depilation district, has no that local skin has edema, hyperemia, erythema, petechia and ulcer.
Medication group Cavia porcellus chroma of hair, ingest, the matched group no significant difference such as extremity are movable, histopathologic examination, the administration group heart,
Liver, kidney and depilation skin compare also no significant difference with compareing word.
Result is pointed out, and Chinese medicine cold compress bag of the present invention, without local irritant effect, also has no that general toxicity shows.Show the present invention
Chinese medicine cold compress bag uses safety.
Long term toxicity test data
1, experimental technique
Random for Cavia porcellus part is become 4 groups, often group 15.In guinea pig back spinal column both sides, depilatory is uniformly coated with so that it is de-
Hair scope about 40 square centimeters.Clean depilatory, often organize Cavia porcellus after observing 24 hours and lose money in a business respectively inventive embodiments 1, embodiment 3
With the cold compress bag of embodiment 7, another group is coated with the every twice-daily of solvent 0.8ml, continuous 30 days, observes the ordinary circumstance of Cavia porcellus, experiment
Put to death animal after end and carry out hematology, blood biochemical and pathological examination.
2, result
Above-mentioned three groups of medication Cavia porcellus trunks go to hair-fields, have no that local skin has edema, hyperemia, erythema, petechia and ulcer.
Medication group and control animals chroma of hair, ingest, matched group no significant difference, blood biochemistry checking, the medication such as extremity are movable
Group and matched group are all in normal range.Histopathologic examination, tests each group of heart, liver, kidney and local skin and is showed no obvious disease
Become.
Cold compress bag long-term prescription of the present invention is showed no obvious toxic action to local skin and whole body important organ.Test
Result shows, cold compress bag experiment safety of the present invention.
The pharmacodynamics test of test example 4 cold compress bag
1. experiment material
1.1 test medicine: the sample 1-3 of embodiment 1,3,7 preparation, make epoxy resin the thin slice of 2mm thickness, are immersed in
Medication after 5min in medicinal liquid.
1.2 laboratory animals: BALB/c mouse, ICR mice, body weight is 18 ± 1g, male and female half and half.
2. experimental technique
2.1 therapeutic administratp itching-relieving action to dextran induced mice whole skin pruritus
ICR mice is randomly divided into 4 groups by body weight grade, respectively model control group, sample 1-3 group, often group 10.With
I.e. observe to each group of mouse tail vein injection 0.025% dextran 0.05ml/10g (1.25mg/kg).Mice after half an hour
Skin plays unhairing at erythema, returns after cleaning, and group 1-3 carries out cold compress to mice erythema position, and matched group does not processes;With mice fore paw
Scratch trunk, mouth of head, rear solid end of scratching stings each position of whole body as pruritus indication.In observed and recorded 1h, 6h, mice is scratched where it itches number of times
And scratch where it itches the persistent period.
2.2 therapeutic administratp cause the antiallergic effect of mouse skin allergy to histamine
By body weight grade, BALB/c mouse is randomly divided into 4 groups, and respectively model control group, sample 1-3 group, often organize 10
Only.To each group of mouse tail vein injection 0.5% azovan blue normal saline solution 5mg/kg.In mouse web portion center in advance immediately
The intradermal injection 0.1% histamine phosphate 0.1ml/ at skin that lost hair or feathers only, forms a cuticle mound.Little Corium Mus mound portion is carried out by group 1-3
Cold compress, matched group does not processes;After 2h, mice is taken off cervical vertebra lethal, cuts abdominal part open, cut skin of abdomen, be laid on glass plate,
Measure the longest diameter of injection site locus coeruleus and major diameter normal thereto, calculate the face of skin locus coeruleus by oval area formula
Long-pending (S=π AB).Peel abdominal part indigo plant dye skin, shred with operating scissors and put in test tube, add 4ml acetone-normal saline (7: 3) and mix
Close liquid, shaking.After soaking 24h, 2000r/min is centrifuged 10min, takes supernatant colorimetric at spectrophotometer 610nm, records OD
Value.Locus coeruleus area and OD value result represent with mean ± standard deviation (x ± s), compare employing one factor analysis of variance and carry out between group
Statistical procedures.
Suppression ratio=(model comparison class value-intervention class value)/model comparison class value × 100%.
3, experimental result
Table 2 cold compress bag itching-relieving action to dextran induced mice whole skin pruritus
Note:--represent that number of times is too much, disregard.
After using tail vein injection dextran method to cause mouse systemic skin pruritus, mice occurs that pruritus is reacted, can
To observe that scratch head, rear solid end of fore paw is scratched trunk, mouth stings the action of systemic sites.As seen from Table 2, sample 1-3 is given cold
After Fuing, pruritus number of times and pruritus persistent period substantially reduce, and have pole significant difference (P < 0.01) with model control group, wherein
The effect of sample 3 is the most obvious.
Table 3 cold compress bag causes the impact of mice subcutaneous locus coeruleus area to histamine
Group | Number of animals | Locus coeruleus area (mm2) | Suppression ratio (%) |
Model control group | 10 | 504.32±150.6 | 0 |
1 group of sample | 10 | 375.42±110.64 | 35.25 |
2 groups of sample | 10 | 294.20±58.41 | 54.46 |
3 groups of sample | 10 | 265.78±61.04 | 65.15 |
After tail vein injection azovan blue, hypodermic histamine phosphate may result in mouse skin allergy reaction, forms skin
Lower locus coeruleus.As seen from Table 3, after giving cold compress bag cold compress, after 2h, the backboard area of sample 1-3 all reduces, and has with model control group
Significant difference (P < 0.01), and backboard area suppression ratio all reaches more than 35%, the wherein best results of sample 3, suppression ratio
Reach 65.16%.
Model case
Case 1: Chen, man, 34 years old, suffer from skin allergy, went to chronic dermatosis well because anaphylactogen is untreated the year before last,
Show as chronic eczema, the cold compress bag of the cold compress embodiment of the present invention 73 days after half a year, every day cold compress 4h, effect is notable, continues again
About cold compress two weeks, eczema disappears;Eczema of recurrence the most after two months, cold compress disappeared after 7 days;The most not multiple
Send out.
Case 2: Lee, man, 23 years old, it to be engaged in slaughtering industry, suffer from skin pruritus for many years, skin lines thickens, and is dried, office
Portion is red and swollen, the cold compress bag of the cold compress embodiment of the present invention 46 days, and every day, cold compress was not less than 4h, was almost recovered, and red and swollen disappearance, skin is extensive
Compound light pool.
Case 3: Wang, female, 38 years old, scabies pruritus had 10 years, uses various Chinese and western medicine and hormone therapy, and symptom fails to delay
Solution increases the weight of on the contrary, for a long time and Folium Styracis Suberifoliae increases the weight of, day and night scratch and itch very, agonizing.After cold compress bag of the present invention is carried out cold compress to affected part,
Every day, cold compress was not less than 3h, and within 7 days, the state of an illness significantly alleviates, and when 15 days, whole body pruritus, lamellar prurigo, all diseases all alleviate, and spot is basic
Disappearing, the place of skin darkening has reduced, after two months, and transference cure, with side after 1 year, does not recurs.
Case 4: Zhang, 56 years old, urticaria: whole body is very itched, lamellar redness shape antisensitizer flickering, long-term is invalid,
Doctor is invalid for a long time.Affected part is carried out cold compress by cold compress bag of the present invention, and every day, cold compress was not less than 5h, continues 5 days state of an illness of medication and significantly subtracts
Gently, after 20 days, whole body pruritus, lamellar erythema disappear substantially, urticaria Periostracum Cicadae when 2 months, continue the drug of topical application pull out again whole body it
Poison, skin surface is smooth, and color is identical with surrounding, and latter 6 months without recurrence.
Claims (9)
1. treat a cold compress bag for anaphylaxis dermatosis, including bag, it is characterised in that described bag includes being overlapped mutually and sets
The medicated bag put and condensation bag, separated by the non-woven fabrics that thickness is 1-5mm, outside described medicated bag between described medicated bag and condensation bag
Being made up of waterproof fabrics, described condensation bag is made up of non-woven fabrics;
Described medicated bag includes that the content in bag and liquid medicine, described content are mainly prepared from by following crude drug: Herba portulacae
3-12 weight portion, Radix Arnebiae (Radix Lithospermi) 2-6 weight portion, Herba Sonchi Oleracei 3-9 weight portion, Radix Notoginseng 1-5 weight portion, Herba Euphorbiae Helioscopiae 1-5 weight portion, Semen Hydnocarpi
0.5-3 weight portion, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan 0.5-3 weight portion;
Described liquid medicine is mainly prepared from by following crude drug: Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) 10-20 weight portion, Radix Astragali 10-20 weight portion, Herba Achilleae
10-20 weight portion, Cortex Phellodendri 5-18 weight portion, Herba Senecionis Scandentis 5-15 weight portion, Indigo Naturalis 5-15 weight portion, Spica Prunellae 3-11 weight portion,
Cortex Mori 5-15 weight portion;
Described condensation bag includes that epoxy resin, described epoxy resin are mainly prepared from by following raw material: Carboxymethyl cellulose sodium 50-80
Weight portion, hydrogenated wood rosin glycerol ester 10-30 weight portion, menthyl lactate 5-20 weight portion, Oleum menthae 0.5-3 weight portion.
2. the cold compress bag treating anaphylaxis dermatosis as claimed in claim 1, it is characterised in that prepare described content and also wrap
Include following crude drug: Flos Lonicerae 3-9 weight portion, Radix Glycyrrhizae Preparata 1-5 weight portion, Radix Paeoniae Alba 1-5 weight portion, store 0.5-3 weight portion, Cicadae
Slough off 0.5-3 weight portion.
3. the cold compress bag treating anaphylaxis dermatosis as claimed in claim 2, it is characterised in that prepare described liquid medicine and also include
Following crude drug: Medulla Junci 5-20 weight portion, Radix Dipsaci 5-15 weight portion, Rhizoma Acori Graminei 5-15 weight portion, Radix Platycodonis 1-5 weight portion is fresh
Rhizoma Phragmitis 1-5 weight portion, Fructus Gardeniae 3-9 weight portion.
4. the cold compress bag treating anaphylaxis dermatosis as claimed in claim 1, it is characterised in that prepare described condensation bag and also wrap
Include following raw material: sorbitol 2-8 weight portion, poloxamer 10-20 weight portion.
5. the cold compress bag of the treatment anaphylaxis dermatosis as according to any one of claim 1-4, it is characterised in that described content
Thing also includes adjuvant, and in described content, the ratio of weight and number of crude drug and adjuvant is 1:0.5-3;Described adjuvant includes linoleic acid
10-30 weight portion, sodium dehydroacetate 8-20 weight portion, sodium salicylate 3-12 weight portion.
6. the cold compress bag treating anaphylaxis dermatosis as claimed in claim 5, it is characterised in that described adjuvant also includes Bentonite
15-35 weight portion and colloidality silica 1 0-25 weight portion.
7. the as claimed in claim 1 cold compress bag treating anaphylaxis dermatosis, it is characterised in that described medicated bag and condensation bag it
Between nonwoven thickness be 2.2mm.
8. the cold compress bag treating anaphylaxis dermatosis as claimed in claim 1, it is characterised in that the nothing outside described condensation bag
Spinning layer of cloth surface and be provided with tearable cover layer, described cover layer is polyethylene film cover.
9. a preparation method for the cold compress bag for the treatment of anaphylaxis dermatosis as claimed in claim 6, comprises the steps:
(1) preparation of content: weigh the Herba portulacae of formula ratio, Radix Arnebiae (Radix Lithospermi), Herba Sonchi Oleracei, Radix Notoginseng, Herba Euphorbiae Helioscopiae, Semen Hydnocarpi, Isodonpubescens (Hemsl.) C. Y. Wuet Hsuan, gold
Flos Lonicerae, Radix Glycyrrhizae Preparata, the Radix Paeoniae Alba, storage and Periostracum Cicadae, pulverize, and crosses 60 mesh sieves, obtains content;
(2) preparation of liquid medicine:
(2.1) take the Ramulus et folium glochidionis eriocarpi (Folium Glochidii Eriocarpi) of described weight portion, Radix Platycodonis, Spica Prunellae, fresh Rhizoma Phragmitis distillation extraction, obtain volatile oil, and collect steaming
Aqueous solution after evaporating;
(2.2) weigh the Herba Achilleae of formula ratio, Cortex Phellodendri, Herba Senecionis Scandentis, Indigo Naturalis, Cortex Mori, Medulla Junci, Radix Dipsaci, Rhizoma Acori Graminei, the Radix Astragali,
After Fructus Gardeniae boiling 3 hours, add the medicinal residues after distillation in step (2.1), boiling twice, each 1 hour, merge
Decoction liquor, filters, and after filtration, the aqueous solution with step (2.1) merges, and is concentrated into magma shape, is cooled to room temperature, adds ethanol and makes to contain
Alcohol amount is 65%, stirring, stands 24 hours, after taking supernatant recovery ethanol, obtains liquid medicine;
(3) by the content of step (1) and the liquid medicine mixing and stirring of step (2) of preparation, add formula ratio linoleic acid,
Bentonite, colloidality silicon dioxide, sodium dehydroacetate and sodium salicylate, after mix homogeneously, obtain medicated bag mixture, standby;
(4) preparation of epoxy resin
(4.1) weigh the Carboxymethyl cellulose sodium of formula ratio, hydrogenated wood rosin glycerol ester and poloxamer, add appropriate deionized water and mix
Close uniformly, obtain mixed liquor, standby;
(4.2) menthyl lactate weighing formula ratio is dissolved in ethanol, obtains menthyl lactate ethanol solution, standby;
(4.3) weigh Oleum menthae and the sorbitol of formula ratio, and add mixed liquor and the lactic acid of step (4.2) of step (4.1)
Menthyl ester ethanol solution, adds suitable quantity of water regulation viscosity, stirs, obtain epoxy resin;
(5) preparation of bag is condensed: the epoxy resin that step (4.3) prepares is spread evenly across non-woven fabrics inner face, then by non-woven fabrics
Side presses polyethylene film outside non-woven fabrics and covers together with sewing with medicated bag inside edge, obtains non-fill medicated bag
Cold compress bag;
(6) the medicated bag mixture that step (3) prepares is poured in step (5) in the medicated bag of cold compress bag, sealing, packaging, must control
Treat the cold compress bag of anaphylaxis dermatosis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610568004.9A CN106177075A (en) | 2016-07-17 | 2016-07-17 | The cold compress bag for the treatment of allergic skin and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610568004.9A CN106177075A (en) | 2016-07-17 | 2016-07-17 | The cold compress bag for the treatment of allergic skin and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106177075A true CN106177075A (en) | 2016-12-07 |
Family
ID=57493462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610568004.9A Pending CN106177075A (en) | 2016-07-17 | 2016-07-17 | The cold compress bag for the treatment of allergic skin and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106177075A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109700862A (en) * | 2019-03-13 | 2019-05-03 | 山东朱氏药业集团有限公司 | Photon epoxy resin and manufacture the photon epoxy resin complete production line |
-
2016
- 2016-07-17 CN CN201610568004.9A patent/CN106177075A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109700862A (en) * | 2019-03-13 | 2019-05-03 | 山东朱氏药业集团有限公司 | Photon epoxy resin and manufacture the photon epoxy resin complete production line |
CN109700862B (en) * | 2019-03-13 | 2022-02-01 | 山东朱氏药业集团有限公司 | Photon condensate and matched production line for manufacturing photon condensate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103860699B (en) | A kind of pharmaceutical composition for effecting a radical cure three-hypers | |
CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
CN102247479B (en) | Antitumor strong medicine and preparation method thereof | |
CN102940822B (en) | Synovitis treating medicine and preparation method thereof | |
CN102579658A (en) | Traditional Chinese medicinal composition for curing hyperuricacidemia, gout and urinary retention | |
CN104857366A (en) | Preoperative intervention medicine composition for neurosurgery and application thereof | |
CN103989907A (en) | Traditional Chinese medicine composition for treating amyloidosis cutis | |
CN1311854C (en) | Medicinal composition for treating traumatic surface | |
CN106177075A (en) | The cold compress bag for the treatment of allergic skin and preparation method thereof | |
CN105148156A (en) | Traditional Chinese medicine composition for treating bedsores and preparation method thereof | |
CN101057922A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
CN104644857A (en) | Traditional Chinese medicine formula for treating acnes | |
CN114306442A (en) | Traditional Chinese medicine composition for treating atopic dermatitis and application thereof | |
CN107050177A (en) | It is a kind of to be used to treat Chinese medicine composition of acne and preparation method thereof | |
CN105327244A (en) | Traditional Chinese medicine composition containing folium artemisiae argyi and used for treating bedsores and preparing method thereof | |
CN105213609A (en) | A kind of Chinese medicine composition for the treatment of decubital ulcer and preparation method thereof | |
CN106177352A (en) | The cold compress bag for the treatment of rheumatoid arthritis and preparation method thereof | |
CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
CN105169183A (en) | Traditional Chinese medicine composition for treating bedsores and preparation method thereof | |
CN105343313A (en) | Traditional Chinese medicinal composition for treating senile skin pruritus and preparation method of traditional Chinese medicinal composition | |
CN101337026A (en) | External medicine composition for treating gout | |
CN111214584B (en) | Traditional Chinese medicine composition for tonifying kidney and benefiting liver as well as preparation method and application thereof | |
CN103520475B (en) | A kind of pharmaceutical composition being used for the treatment of skin pruritus | |
CN102552711A (en) | Chinese medicinal composition for treating hypertension | |
CN1311849C (en) | Medicinal composition for treating swelling paint |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161207 |
|
WD01 | Invention patent application deemed withdrawn after publication |